Advantages over probiotics:
Product stability: Unlike probiotics, Pylopass™ consists of spray-dried cells which can withstand environmental fluctuations. For shipment and storage, Pylopass™ does not require temperature controls. Specificity for H. pylori:
While probiotics cater to general gut health, Pylopass™ specifically binds H. pylori in the stomach. Furthermore, Pylopass™ does not bind or disturb the normal gut microbial balance. Stability in gastric conditions: In contrast to probiotics, Pylopass™ employs a mechanism which is not dependent on survival in the gastric environment. Probiotics can be beneficial because they may replace harmful bacteria in the gastrointestinal tract.
However it is uncertain whether such living probiotic strains can withstand the acidic environment in the stomach. This concern is not a challenge for Pylopass™ as the coaggregation depends only on the binding of surface structures between Pylopass™ and H. pylori.
Ingredients: Lactobacillus reuteri, Zinc-L-Carnosine, Maltodextrin
–Pylopass™ is a proprietary strain of Lactobacillus reuteri which specifically coaggregates with Helicobacter pylori in the stomach to reduce the bacterial load. Pylopass™ is comprised of spray-dried L. reuteri cells and is stable in a wide range of applications for the end consumer market.
-The Pylopass™ strain of L. reuteri was identified after a detailed, multi-year screening process. It was selected as a highly specific binding antagonist to H. pylori among more than 700 wild-type strains of Lactobacillus species of the ORGANOBALANCE culture collection of several thousand food grade strains. Through a specific mechanism, Pylopass™ forms coaggregates with H. pylorito decrease the overall load in the stomach.
The recommended daily dose should not be exceeded.
Do not use after the expiry date which is stated on the pack.
Do not replace the varied diet with Lactoflor Helico protect.
Store below 25 ° C in a dry, inaccessible place for children.
Packing: 15 capsules.
-The surface structures on Pylopass™ contain adhesion molecules that recognize and adhere to surface structures on H. pylori.
-After coaggregation in the stomach has occurred, the entire coaggregate is excreted from the body through the digestive tract. Pylopass™ specifically binds to H. pylori and does not alter the microflora of the gut.